%20Abstract%20Background%20102024%20SOURCE%20Amazon.jpg)
Hims & Hers Has a Superpower in Healthcare
This isn't just any growth stock.
Hims & Hers (NYSE: HIMS) CEO Andrew Dudum isn't interested in taking insurance onto his platform, and that shows how disruptive the company could be. This could be the next great growth stock if Dudum's plans to aggregate demand play out as hoped.
*Stock prices used were end-of-day prices of May 6, 2025. The video was published on May 7, 2025.
